Monday, February 24, 2020

Pharma Reviews: 'Limited immediate risk from Covid-19 to India pharma sector'

Mumbai, Feb 24 (IANS) The immediate risk to the Indian pharma industry from the supply shortages of key raw materials from China due to ...
Read more: 'Limited immediate risk from Covid-19 to India pharma sector'